title: Risk reduction for stroke and coronary events.
authors.forename: Hakim
authors.initials: H
authors.lastname: Mazouz
authors.forename: Raifah
authors.initials: R
authors.lastname: Makdassi
authors.forename: Christophe
authors.initials: C
authors.lastname: Tribouilloy
authors.forename: Gabriel
authors.initials: G
authors.lastname: Choukroun
authors.forename: Michel
authors.initials: M
authors.lastname: Andrejak
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001581:Benzothiadiazines; D002986:Clinical Trials as Topic / Q000379:methods*; D004232:Diuretics; D006801:Humans; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D020521:Stroke / Q000517:prevention & control*
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors